Clinical Trials Logo

Filter by:
NCT ID: NCT02746328 Withdrawn - Clinical trials for ER+ and AR+ Breast Cancer

Add-on Study for Protocol G200802 (NCT02463032): Effect of GTx-024 on Maximal Neuromuscular Function and Lean Body Mass

Start date: April 2016
Phase: Phase 2
Study type: Interventional

This is a multiple site, proof of concept feasibility study to describe the effect of GTx-024 9 or 18 mg on physical function in female subjects, from protocol G200802, with ER+/AR+ breast cancer.

NCT ID: NCT02753205 Withdrawn - Clinical trials for Intracranial Hypertension

Dexmedetomidine on Optic Nerve Sheath Diameter

Start date: April 2016
Phase: N/A
Study type: Interventional

Dexmedetomidine, might attenuate the sympathetic activation and contribute to stable hemodynamics. The investigator hypothesized that continuous infusion of dexmedetomidine during laparoscopic lower abdominal surgery, might help to attenuate the increment of intracranial pressure and the investigator would observe the optic nerve sheath diameter using ultrasonography.

NCT ID: NCT02766842 Withdrawn - Lymphoma Clinical Trials

Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)

Start date: April 2016
Phase: Phase 2
Study type: Interventional

Diagnosis of lesions of pancreas, the upper gastrointestinal tract, as well as adjacent structures, such as lymph nodes, is still showing advancements especially with the increased use of endoscopic ultrasound. Endoscopic ultrasound-guided fine needle aspiration and fine needle biopsy (EUS-FNA/FNB) have become mainstay diagnostic techniques for these lesions. The purpose of the study is to compare between the currently used, ProCore needles and the new biopsy needle, SharkCore, for the histological diagnosis and evaluation of lesions.

NCT ID: NCT02772575 Withdrawn - Liver Cancer Clinical Trials

A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)

Start date: April 2016
Phase: N/A
Study type: Observational

The purpose of this study is to see if certain genes the tumor can help predict how the tumor will respond to Trans-Arterial Embolization (TAE). A gene is the basic physical and functional unit of heredity. Genes are made up of DNA; DNA (deoxyribonucleic acid) is the hereditary material in humans. Identifying a gene that can predict how liver tumors will respond to TAE will also help to determine if adjuvant therapy will be needed after TAE.

NCT ID: NCT02779257 Withdrawn - Clinical trials for Gastro-enteropancreatic Neuroendocrine Tumor

Pasireotide Treatment for Neuroendocrine Tumor

Start date: April 2016
Phase: Phase 4
Study type: Interventional

Pasireotide binds to somatostatin receptors sst2 and sst5, which can lead to significant hyperglycemia. The investigators would like to administer pasireotide as a treatment for refractory hypoglycemia in the setting of metastatic insulin-producing pancreatic neuro-endocrine tumor.

NCT ID: NCT02787421 Withdrawn - Clinical trials for Nasal Valve Compromise

Nasal Dilator Strips for Rhinoplasty

Start date: April 2016
Phase: N/A
Study type: Interventional

In this study, the study team will investigate the validity and role of nasal dilator strips (NDS), a novel method to determine the site of nasal valve compromise (NVC), in the pre-operative evaluation. The method involves placing the strip sequentially at the upper and lower lateral cartilage and recording the location of the optimal airway based on patient's subjective symptoms. Investigators seek to assess surgical outcomes in participants undergoing rhinoplasty based on pre-operative NDS classification. The Nasal Obstruction and Septoplasty Effectiveness (NOSE) instrument will be used to evaluate subjective symptoms of nasal obstruction, before and after the operation and comparing these scores.The results will help determine the effectiveness and predictive value of NDS in isolating the site of NVC.

NCT ID: NCT02795715 Withdrawn - Clinical trials for Associative Learning

tDCS Effects on Associative Learning in Younger Adults

TRAINSTIM2
Start date: April 2016
Phase: N/A
Study type: Interventional

The aim of this study is to investigate whether a tDCS-accompanied training of audio-visual associative memory leads to a performance improvement in healthy older individuals."

NCT ID: NCT02799914 Withdrawn - Clinical trials for Venous Vascular Diseases and Syndromes

Evaluation of the Sinus-Venous Stent for the Treatment of Iliofemoral Venous Occlusive Disease

Start date: April 2016
Phase:
Study type: Observational

Post market clinical follow-up study about the Sinus-venous stent. Patients with venous iliofemoral occlusive disease are treated with the Sinus-venous stent. This observational study will provide 1 year data about safety and efficacy.

NCT ID: NCT02882646 Withdrawn - Stroke Clinical Trials

Usability Testing of a Bilateral Activities of Daily Exercise Robot for Stroke Therapy

BiADLER
Start date: April 2016
Phase: N/A
Study type: Interventional

In stroke rehabilitation, unilateral training of the impaired limb after stroke is often the frequent strategy used over bilateral ones. However, the clinical need for bilateral training is supported by evidence that shows that unilateral training of the impaired limb does not automatically restore bimanual coordination and function. Increased focused is needed on developing more robot-assisted therapy that can train the impaired arm bilaterally and unilaterally. Controlling these robots is often difficult and requires a better understanding of the coupling effects of the left and right hand before and after a stroke. There is a need to develop robot-assisted therapy devices that can address coupled and uncoupled bimanual movements as well as symmetry as well as asymmetry in context of human bimanual actions along with the intermanual division of labor in various ADL tasks. This study focuses on bilateral training and the use of bio-inspired control algorithms to understand impairment and recovery on Bimanual Activities of Daily Living (ADLs) by stroke subjects in terms of the arm kinematics. Healthy subjects and those with hemiplegia due to a stroke or cerebral palsy will be evaluated by a member of the research team and asked to perform a battery of tasks to test the viability and usability of a bilateral robot system called BiADLER, which allows patients to complete daily tasks with varying levels of assistance to adapt task performance to each individual subject's performance. Subjects will to provide feedback to the researchers on their observations and thoughts about the therapy devices.

NCT ID: NCT02911480 Withdrawn - Clinical trials for Healthy Women of Child Bearing Potential

Assessment of Pharmacokinetics and Bioavailability of Carbon-14 ([14C])-Labelled Oxytocin

Start date: April 2016
Phase: Phase 1
Study type: Interventional

The current study is designed as a phase I multiple dose study to evaluate the pharmacokinetics and bioavailability of [14C]-labelled oxytocin in healthy women.